Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 141, Issue 3, 2011, Pages 662-670

  Darling, Gail E ^a   Allen, Mark S ^b   Decker, Paul A ^b   Ballman, Karla ^b   Malthaner, Richard A ^c   Inculet, Richard I ^c   Jones, David R ^d   McKenna, Robert J ^e   Landreneau, Rodney J ^f   Rusch, Valerie W ^g   Putnam Jr , Joe B ^h  

^a UNIVERSITY OF TORONTO   (Canada)

^b MAYO CLINIC   (United States)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF VIRGINIA   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ACOSOG; American College of Surgery Oncology Group; CI; computed tomography; confidence interval; CT; mediastinal lymph node dissection; mediastinal lymph node sampling; MLND; MLNS; non small cell lung cancer; NSCLC; VATS; video assisted thoracic surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LUNG HILUS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE SAMPLING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SAMPLING; SURVIVAL TIME;

EID: 79951767248     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.11.008     Document Type: Article

References (18)

1. Altekruse SF, Kosary CL, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER website, 2010.
2. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg. 2005;80:2051-6. (Pubitemid 41718027)
3. Wu Y, Huang ZF, Wang SY, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 2002;36:1-6. (Pubitemid 34224887)
4. Caglar HB, Baldini EH, Othus M, et al. Outcomes of patients with stage III non-small cell lung cancer treated with chemotherapy and radiation with and without surgery. Cancer. 2009;115:4156-66.
5. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718-23. (Pubitemid 27260108)
6. AllenMS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81:1013-20. (Pubitemid 43247678)
7. Darling GE, Allen MS, Decker PA, et al. Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective ACOSOG ZOO30 trial. Accepted for publication. Chest. 2010 Sep 9 [Epub ahead of print].
8. Johnson J, Kirby CK, Blackmore WS. Should we insist on radical pneumonectomy as routine procedure in the treatment of carcinoma of the lung? J Thorac Surg. 1958;36:309-15.
9. Shimkin MB, Connelly RR, Marcus SC. Pneumonectomy and lobectomy in bronchogenic carcinoma: a comparison of end results of the Overholt and Ochsner clinic. J Thorac Surg. 1962;44:503-19.
10. Cahan WG, Watson WL, Pool JL. Radial pneumonectomy. J Thorac Surg. 1951; 22:449-73.
11. Martini N. Mediastinal lymph node dissection for lung cancer. The Memorial experience. Chest Surg Clin N Am. 1995;5:189-203.
12. Doddali C, Aragon A, Barlesi F, Chetaille B, Robitail S. Does the extent of lymph node dissection influence outcome in patients with stage I non-small cell lung cancer? Eur J Cardiothorac Surg. 2005;27:680-5.
13. Gajra A, Newman N, Gamble GP, et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 2003;21:1029-34. (Pubitemid 46594131)
14. Sugi K, Nawata K, Fujita N, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg. 1998;22:290-5. (Pubitemid 28113402)
15. Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg. 2000;70:358-65.
16. Izbicki JR, Passlick B, Pantel K, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg. 1998;227:138-44. (Pubitemid 28071349)
17. Wright G, Manser RL, Byrnes G, et al. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax. 2006;61:597-603. (Pubitemid 44035140)
18. Manser R, Wright G, Hart D, et al. Surgery for early stage non-small cell lung cancer (Cochrane Review). In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons; 2005.